Publications by authors named "Xu Musheng"

Claim this Profile
D
Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases.
Robert A Craig, Javier De Vicente, Anthony A Estrada, Jianwen A Feng, Katrina W Lexa, Musheng Xu

J Med Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resin-based iron-manganese binary oxide for phosphate selective removal.
Jie Wang, Yongcan Jiang, Musheng Xu, Cong Han, Lichao Zhang

Environ Sci Pollut Res Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.
Robert A Craig, Brian M Fox, Cheng Hu, Katrina W Lexa, Maksim Osipov, Musheng Xu

J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring boron applications in modern agriculture: A structure-activity relationship study of a novel series of multi-substitution benzoxaboroles for identification of potential fungicides.
Chunliang Liu, Luke Steere, Cari McGregor, Brittany H Frederick, Timothy Pastoor, Musheng Xu

Bioorg Med Chem Lett· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with Efficacy in Multiple Myeloma.
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Irene de Miguel, Musheng Xu

J Med Chem· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Musheng Xu

ACS Chem Neurosci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Xu Musheng

ACS Chem Neurosci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces.
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, Xabier Agirre, Irene de Miguel, Musheng Xu

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Amaia Vilas-Zornoza, Musheng Xu

J Med Chem· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents.
Irene de Miguel, Josune Orbe, Juan A Sánchez-Arias, José A Rodríguez, Agustina Salicio, Musheng Xu

ACS Med Chem Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Xu Musheng

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT).
Tsutomu Akama, Yong-Kang Zhang, Yvonne R Freund, Pamela Berry, Joanne Lee, Musheng Xu

Bioorg Med Chem Lett· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease.
Juan A Sánchez-Arias, Obdulia Rabal, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Xu Musheng

ACS Chem Neurosci· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Xu Musheng

J Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.
Josune Orbe, Juan A Sánchez-Arias, Obdulia Rabal, José A Rodríguez, Agustina Salicio, Musheng Xu

J Med Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone.
Xianfeng Li, Yong-Kang Zhang, Jacob J Plattner, Weimin Mao, M R K Alley, Musheng Xu

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photogeneration and chemistry of biphenyl quinone methides from hydroxybiphenyl methanols.
Musheng Xu, Matthew Lukeman, Peter Wan

Photochem Photobiol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketonization of the remarkably strongly acidic elongated enol generated by flash photolytic decarboxylation of p-benzoylphenylacetic acid in aqueous solution.
Yvonne Chiang, A Jerry Kresge, Ikenna Onyido, John P Richard, Peter Wan, Musheng Xu

Chem Commun (Camb)· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photohydration and photosolvolysis of biphenyl alkenes and alcohols via biphenyl quinone methide-type intermediates and diarylmethyl carbocations.
Darryl W Brousmiche, Musheng Xu, Matthew Lukeman, Peter Wan

J Am Chem Soc· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excited state intramolecular redox reaction of 2-(hydroxymethyl)anthraquinone in aqueous solution.
Matthew Lukeman, Musheng Xu, Peter Wan

Chem Commun (Camb)· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis